Literature DB >> 14576359

Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin.

R Matthew Klein1, Mingzhe Zheng, Anthony Ambesi, Livingston Van De Water, Paula J McKeown-Longo.   

Abstract

The fibronectin matrix contains cryptic sites which are thought to modulate cellular biological responses. One of these sites, located in fibronectin's first type III repeat (III1c), influences signaling pathways that are relevant to cytoskeletal organization and cell cycle progression. The purpose of this study was to identify possible mechanisms responsible for the effects of III1c on cell behavior. Recombinant peptides representing various type III repeats of fibronectin were compared for their effects on fibronectin matrix organization and activation of intracellular signaling pathways. III1c and III13 but not III11c or III10 bound to monolayers of human skin fibroblasts in a dose- and time-dependent manner and were localized to the extracellular matrix. Binding of III13, but not III1c, to matrix was sensitive to heparitinase, suggesting that the association of III1c with the matrix was not dependent on heparan sulfate proteoglycans. Quantitative and morphological assessment indicated that, in contrast to previously published reports, the binding of III1c to cell layers did not result in the loss or disruption of matrix fibronectin. Binding of III1c but not III13 to the extracellular matrix did result in the loss of a conformationally sensitive epitope present within the EDA type III module of cellular fibronectin. III1c-induced loss of the EDA epitope did not require the presence of cells, occurred within 1 hour and was associated with the activation of p38 mitogen-activated protein kinase (MAPK) followed by the formation of filopodia. Maximal phosphorylation of p38 MAPK occurred within 1 hour, whereas cytoskeletal changes did not appear until 12 hours later. These findings are consistent with a model in which the binding of III1c to the extracellular matrix results in a conformational remodeling of the fibronectin matrix, which has both short- and long-term effects on cell physiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576359     DOI: 10.1242/jcs.00778

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  23 in total

1.  The first type III repeat in fibronectin activates an inflammatory pathway in dermal fibroblasts.

Authors:  Ran You; Mingzhe Zheng; Paula J McKeown-Longo
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Regulation of p38 MAP kinase by anastellin is independent of anastellin's effect on matrix fibronectin.

Authors:  Ran You; R Matthew Klein; Mingzhe Zheng; Paula J McKeown-Longo
Journal:  Matrix Biol       Date:  2009-02-04       Impact factor: 11.583

3.  The α4β1 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts.

Authors:  Arti V Shinde; Rhiannon Kelsh; John H Peters; Kiyotoshi Sekiguchi; Livingston Van De Water; Paula J McKeown-Longo
Journal:  Matrix Biol       Date:  2014-11-26       Impact factor: 11.583

4.  Conformational remodeling of the fibronectin matrix selectively regulates VEGF signaling.

Authors:  Anthony Ambesi; Paula J McKeown-Longo
Journal:  J Cell Sci       Date:  2014-06-30       Impact factor: 5.285

5.  Integrin α4β1 and TLR4 Cooperate to Induce Fibrotic Gene Expression in Response to Fibronectin's EDA Domain.

Authors:  Rhiannon M Kelsh-Lasher; Anthony Ambesi; Ceyda Bertram; Paula J McKeown-Longo
Journal:  J Invest Dermatol       Date:  2017-08-24       Impact factor: 8.551

6.  MT1-MMP regulates the turnover and endocytosis of extracellular matrix fibronectin.

Authors:  Feng Shi; Jane Sottile
Journal:  J Cell Sci       Date:  2011-12-08       Impact factor: 5.285

7.  Cryptic activity within the Type III1 domain of fibronectin regulates tissue inflammation and angiogenesis.

Authors:  Christina Cho; Rhiannon Kelsh-Lasher; Anthony Ambesi; Paula J McKeown-Longo
Journal:  Curr Top Pept Protein Res       Date:  2015

8.  Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.

Authors:  Anthony Ambesi; Paula J McKeown-Longo
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

9.  Display of cell surface sites for fibronectin assembly is modulated by cell adherence to (1)F3 and C-terminal modules of fibronectin.

Authors:  Jielin Xu; Eunnyung Bae; Qinghong Zhang; Douglas S Annis; Harold P Erickson; Deane F Mosher
Journal:  PLoS One       Date:  2009-01-01       Impact factor: 3.240

10.  A novel fibronectin binding motif in MSCRAMMs targets F3 modules.

Authors:  Sabitha Prabhakaran; Xiaowen Liang; Jonathan T Skare; Jennifer R Potts; Magnus Höök
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.